Ken Stuart, Ph.D., is the founder of Seattle Biomedical Research Institute, a nonprofit research organization focused on making discoveries that will lead to new solutions for the world's deadliest diseases including malaria, TB and HIV/AIDS. At SBRI, Stuart heads his own research laboratory while fulfilling broad institute-building roles. His research is focused on unicellular parasites that are estimated to kill around a million people each year. His laboratory utilizes genomics, proteomics and gene function approaches to generate new knowledge needed to develop drugs, diagnostics, and vaccines for diseases. Dr. Stuart is a professor of pathobiology and microbiology at the University of Washington and served as chair of the pathobiology department from 1996-2004. He serves on multiple advisory groups and received a Burroughs Wellcome Scholar in Molecular Parasitology Award, Denis Thienpont Prize in Molecular Parasitology, NIAID MERIT Award, and the Stoll-Stunkard Award from the American Society of Parasitologists.
The burgeoning life sciences/biotech sector here is gratifying and indicates that Seattle isn’t just about airplanes, software and coffee. However, in order for our industry to enjoy the success that others... Read more »
When you hear “Michigan,” the automotive industry and Motown automatically come to mind, much as when someone says “Seattle,” one thinks of software, airplanes and coffee.
That has changed over the... Read more »
In science, success is often measured in small advances in understanding. But in the past decade, technology has led to large leaps of new knowledge that has been well utilized in... Read more »
What does the global health community in Washington need in order to firmly stake our claim as a world leader in this endeavor? That question will be a central topic next... Read more »
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.